Open Access

Aspergillus march: from ABPA to aspergilloma to subacute invasive aspergillosis

  • Vikas Dogra1, 2Email author,
  • Ankit Kumar Sinha2,
  • Rajat Saxena2 and
  • Deepak Talwar2
Allergy, Asthma & Clinical Immunology201612:64

https://doi.org/10.1186/s13223-016-0170-9

Received: 21 April 2016

Accepted: 18 November 2016

Published: 3 December 2016

Abstract

Background

Aspergillus is a ubiquitous fungus responsible for allergic as well as saprophytic and invasive manifestations depending on host’s immune status. The following case report demonstrates progression of allergic manifestations of Aspergillus to its invasive form in an individual with decreasing immunity. This can lead to uncertainties in diagnosis and management.

Case presentation

A 28-year-old male, non smoker, known case of ABPA (allergic bronchopulmonary aspergillosis) was admitted with complaints of cough for 1 month, associated with recurrent episodes of hemoptysis for last 5 days. CT Thorax revealed homogenous dense round opacity in right upper lobe which replaced previous fibrocalcific bronchiectatic lesion with cavity and aspergilloma, bulging across the major fissure with fibrotic strands extending to periphery in all directions. Post-pneumonectomy microscopic examination revealed Aspergillus hyphae invading blood vessels.

Conclusion

There is a need for close clinical and radiologic follow up of patients with Aspergillus and our patient demonstrated overlap of complete spectrum of Aspergillus disease with march from one end to the other end.

Keywords

Asthma Aspergillus Aspergilloma

Background

Aspergillus is a fungus with ubiquitous presence. It is responsible for spectrum of diseases depending upon the host immune status varying from allergic bronchopulmonary aspergillosis (ABPA) in atopics, aspergilloma in chronic lung cavity, and chronic pulmonary aspergillosis (CPA) or invasive pulmonary aspergillosis (IPA) in immunocompromized. However, overlap among them has been observed as immune status changes because of treatment with steroids for ABPA or development of diabetes which itself leads to immunosuppression. We present a rare case with ABPA which progressed to develop aspergilloma and finally to subacute invasive aspergillosis over a period of 10 years.

Case presentation

A 28-year-old male, non smoker, known case of ABPA was admitted with complaints of cough with scant expectoration for 1 month, associated with recurrent episodes of hemoptysis for last 5 days. He had been diagnosed as ABPA 10 years back with Skin Prick Test (SPT) strongly positive for Aspergillus fumigatus, flavus and niger. Total Serum IgE was 1200 KU/L with specific IgE and IgG positive against A. fumigatus. He was on treatment with steroids for the same. 5 years ago he was admitted with mild hemoptysis, fever and breathlessness for 2 weeks. Contrast enhanced CT chest showed mucoid impaction (HAM—High attenuation mucus) and central bronchiectasis in right upper lobe (Fig. 1). He received Itraconazole for 4 months. Subsequently, he had repeated admissions for 3 consecutive years with similar complaints and repeat CT done revealed fibrocalcific lesion in apical and posterior segments of right lung upper lobe with a cavity showing soft tissue attenuation and air crescent sign suggestive of mycetoma (Fig. 2). He was advised surgery, which was deferred by patient and he took Voriconazole for 6 weeks and later itraconazole for 6 months from elsewhere and was lost to follow up. He had been on oral steroids for 10 years receiving on an average 6 months of steroids (Prednisolone starting from 60 mg then tapered). For last 2 years he was on oral Deflazacort 12 mg with doses increased during exacerbations.
Fig. 1

CXR showing right upper lobe opacity which on HRCT showed central bronchiectasis in right upper lobe anterior segment

Fig. 2

HRCT cuts from 2009 to 2014 showing development of aspergilloma in right upper lobe which grew over 5 years

At present admission his resting peripheral capillary oxygen saturation was 89% on room air. Chest X ray revealed hyperinflated lung fields with focal homogenous opacity with infiltrates in right upper zone (Fig. 3). CT Thorax revealed homogenous dense round opacity in right upper lobe which replaced previous fibrocalcific bronchiectatic lesion with cavity and aspergilloma, bulging across the major fissure with fibrotic strands extending to periphery in all directions. Sputum smears and culture examinations for mycobacteria, and fungi were negative.
Fig. 3

A Chest Xray showing opacity right upper lobe B HRCT sagittal cut showing expanded aspergilloma pushing across oblique fissure with peripheral infiltrates

In view of recurrent hemoptysis, unilateral disease and worsening radiological disease with acceptable lung functions, patient underwent thoracotomy. The lesion was found to be extending across major fissure with involvement of right lower lobe apical segment and decision for pneumonectomy was taken. Gross examination of resected lung showed cavity in the upper lobe filled with solid debris (Fig. 4A) which on microscopic examination shows fungal colonies comprising of acutely branching septate fungal hyphae with invasion of surrounding bronchi, alveolar tissues and blood vessels. Surrounding parenchyma showed emphysematous changes with septate branching fungal hyphae and minimal fibrosis of the cavity wall and surrounding pleural consistent with the diagnosis of complex mycetoma with locally invasive aspergillosis (Fig. 4B–D). Few central bronchiectatic segments were seen in the upper lobe.
Fig. 4

A Gross right pneumonectomy specimen with large fungus ball in cavity with fibrosis. B Lung parenchyma blood vessel showing infiltration with fungal hyphae). C Intra bronchial fungal elements. D fungal ball showing acutely branching septate hyphae of Aspergillus

Patient had uneventful recovery and is doing well. His serum galactomannan was 2.5 and given oral voriconazole for 6 weeks and repeat serum galactomannan was negative and now patient is being regularly followed in OPD.

Discussion

Aspergillus causes a spectrum of diseases depending upon the immune status of the host (Table 1) [1].
Table 1

Manifestations of pulmonary aspergillosis

Simple colonization

Allergic bronchopulmonary aspergillosis (ABPA)

Chronic pulmonary aspergillosis

Simple aspergilloma

Chronic cavitary pulmonary aspergillosis (CCPA)

Chronic fibrosing pulmonary aspergillosis

Aspergillus nodule

Subacute invasive aspergillosis (SAIA)

Angioinvasive aspergillosis

Airway invasive aspergillosis

Both ABPA and aspergilloma are its noninvasive forms. Aspergilloma is a fungus ball that develops in a pre-existing cavity within the lung parenchyma, while ABPA is a hypersensitivity manifestation in the lungs that almost always affects patients with asthma or cystic fibrosis. Tissue necrosis and invasion of blood vessels does not occur. Aspergillomas presenting with recurrent hemoptysis are treated by surgery. Our case also highlights failure of antifungals in management of aspergillomas as patient tried though for limited period to avoid surgery.

Subacute invasive pulmonary aspergillosis (SAIA) or Chronic Necrotizing Aspergillosis is a locally invasive disease manifesting as a syndrome of slowly progressive cavitary lung disease, chronic respiratory symptoms, and the presence of precipitating antibodies to Aspergillus [2]. It typically occurs in patients with a depressed immune system, but not as profoundly immunocompromised [2]. It is commonly observed in diabetics, patients on corticosteroids or with underlying lung disease like COPD. SAIA usually runs a slowly progressive course over weeks to months. It is the finding of tissue invasion that allows this entity to be distinguished from the more common aspergilloma.

Invasive pulmonary aspergillosis (IPA) is a severe disease, found in immunocompromised patients. Certain factors have been documented to predispose an individual to IPA (Table 2) [3.
Table 2

Classical risk factors for invasive pulmonary aspergillosis

Prolonged neutropenia (<500 cells/mm3 for >10 days)

Transplantation (highest risk is with lung transplantation and HSCT)

Prolonged (>3 weeks) and high-dose corticosteroid therapy

Hematological malignancy (risk is higher with leukemia)

Chemotherapy

Advanced AIDS

Chronic granulomatous disease

There are reports documenting IPA in immunocompetent patients who do not have the clearly known risk factors especially severe COPD and critically ill patients [4].

Aspergilloma is an unusual complication of ABPA. Cavitation is known to occur in ABPA but still aspergilloma formation is not common. There have been case reports documenting aspergilloma and ABPA in patients with difficult to control asthma [5]. A case series of 179 patients of ABPA out of which eight also had aspergilloma concluded that concurrent presentation of ABPA and aspergilloma was associated with an immunologically severe disease with higher IgE levels and more extensive bronchiectasis and risk of recurrent relapses [6]. Spontaneous disappearance of aspergilloma has been reported in 5% of cases while they rarely have been reported to increase in size [7]. Thickening of cavity wall and adjacent pleura has been demonstrated to be due to hypersensitivity reaction secondary to fungus as its reversible with resolution of aspergilloma. A chronic mycetoma may suddenly breakdown and become a rapidly invasive pulmonary infection.

A case report by Shah et al. found ABPA, AAS (allergic Aspergillus sinusitis), and aspergilloma occurring simultaneously in the same patient [8].

In present case development of ‘Simple Aspergilloma’ in ABPA was observed at follow up, which kept on increasing in size with destruction of surrounding lung parenchyma and pleural thickening converting it into a ‘Complex Aspergilloma’. It eventually became invasive in the same patient. Possible reason might have been immunocompromized due to corticosteroid therapy, which he received for management of ABPA. This presents a unique therapeutic challenge, as corticosteroids are the mainstay for management of ABPA.

Subacute invasive aspergillosis presents clinically with non specific symptoms with mild to moderate hemoptysis. Radiologically dense circumscribed lesion with or without halo sign is seen. Positive Aspergillus on microscopy from biopsy specimen and positive serum antigen test for Aspergillus are also observed. All these features have been demonstrated in our case. In such cases surgical resection is indicated if significant hemoptysis occurs. In addition to serving as a diagnostic tool, serial galactomannan determinations have been suggested to be useful for monitoring the treatment response or as a surrogate endpoint for outcomes of invasive aspergillosis.

Conclusion

Our patient demonstrated overlap of complete spectrum of Aspergillus disease with march from one end to the other end. This case emphasizes importance of regular clinical and radiologic follow up of patients with ABPA.

Abbreviations

abpa: 

allergic bronchopulmonary aspergillosis

cpa: 

chronic pulmonary aspergillosis

ipa: 

invasive pulmonary aspergillosis

spt: 

skin prick test

ham: 

hyper attenuated mucus

ccpa: 

chronic cavitary pulmonary aspergillosis

saia: 

subacute invasive aspergillosis

copd: 

chronic obstructive pulmonary disease

aas: 

allergic Aspergillus sinusitis

Declarations

Authors’ contributions

VD contributed in management and preparation of manuscript. AKS contributed in management and preparation of manuscript. RS did the surgery. DT guided in diagnosis and management. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Ethical approval

Ethics approval was taken from Hospital’s Ethics committee.

Consent for publication

Written consent was taken by the patient before sending this case report for publication.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Rajiv Gandhi Superspeciality Hospital
(2)
Metro Center for Respiratory Diseases, Metro Multispeciality Hospital

References

  1. Denning DW, Cadranel J, Beigelman C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47:45–68.View ArticlePubMedGoogle Scholar
  2. Saraceno JL, Phelps DT, Ferro TJ, et al. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest. 1997;112:541–8.View ArticlePubMedGoogle Scholar
  3. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011;20:156–74.View ArticlePubMedGoogle Scholar
  4. Thommi G, Bell G, Liu J, Nugent K. Spectrum of invasive pulmonary aspergillosis in immunocompetent patients with chronic obstructive pulmonary disease. South Med J. 1991;84(7):828–31.View ArticlePubMedGoogle Scholar
  5. Shah A. Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Eur Respir Rev. 2010;19(118):261–3.View ArticlePubMedGoogle Scholar
  6. Agarwal R, Aggarwal AN, Garg M, Saikia B, Gupta D, Chakrabarty A. Allergic bronchopulmonary aspergillosis with aspergilloma: an immunologically severe disease with poor outcome. Mycopathologia. 2012;174(3):193–201.View ArticlePubMedGoogle Scholar
  7. Pratap H, Dewan RK, Singh L, Gill S, Avaddadi S. Surgical treatment of pulmonary aspergilloma: a series of 72 cases. Indian J Chest Dis Allied Sci. 2007;49:23–7.PubMedGoogle Scholar
  8. Shah A, Panjabi C. Contemporaneous occurrence of allergic bronchopulmonary aspergillosis, allergic Aspergillus sinusitis, and aspergilloma. Ann Allergy Asthma Immunol. 2006;96(6):874–8.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2016

Advertisement